Doctor holding oxygen ambu bag over patient given oxygen to patient by intubation tube in ICU/Emergency room

ACE inhibitors and Angiotensin Receptor Blockers May Increase Mortality Rate In Elderly COVID-19 Patients

These highly prescribed medications change cell surface protein expression, which is particularly problematic in cells in the respiratory system—tissue that is vulnerable to targeting and attack by the COVID-19 virus.
Source: Martin Barraud/Getty Images

10 Countries in 100K Genome Club

These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
DNA research concept DNA barcodes for biomedical research  mitochondrial DNA  Prostate cancer DNA test

8 Companion Diagnostic Developers Making a Mark

If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
Projections for the growth of the liquid biopsy market range as low as $1 billion by 2020

10 Liquid Biopsy Companies in the Money

10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.
Depressed woman with head in hands

UnitedHealthcare To Cover Genetic Testing for Precision Medicine in Depression, Anxiety

The nation’s largest private health insurer, UnitedHealthcare, announced August 1 that it will cover testing that will allow physicians to match their patients to...
Coronavirus

Cepheid, Sherlock to Develop Coronavirus Test, Part of Broader MDx Collaboration

The companies will partner on a proof-of-concept project focused on detection of SARS-CoV-2 coronavirus as the first initiative of a broader collaboration focused on developing molecular diagnostic tests for infectious diseases and oncology.
coronavirus,3d render

Genetic Study Shows Coronavirus Evolved Naturally, Is not Lab-Constructed

Scripps researchers compare available genome sequence data for known coronavirus strains to determine that that SARS-CoV-2 originated through natural processes and note that their results “clearly show that SARS-CoV-2 is not a laboratory construct or a purposefully manipulated virus.”

Small Sequencer Developer GenapSys Completes $90M Series C Financing

GenapSys’ sequencing system is about the size of an iPad, costs under $10,000, and is based on a proprietary direct electronic sequencing chip, which is intended to eliminate the need for cumbersome equipment.
Myanmar: Rhesus Macaque

New Study Suggests COVID-19 Reinfection Unlikely

The study used four adult Chinese rhesus macaques and found that those monkeys that had been re-exposed to SARS-CoV-2, like the unexposed control monkey, showed no recurrence of COVID-19.
coronavirus,3d render

COVID-19 Patients May Carry Virus after Symptoms Have Resolved

The study found that the incubation period of the virus was five days for all but one of the patients, and the average duration of symptoms was eight days. However, the length of time that patients remained contagious after resolution of their symptoms ranged from one to eight days.
Scroll Up